Alcaftadine 0.25% Versus Olopatadine 0.2% In Prevention Of Ocular Itching In Allergic Conjunctivitis

被引：2

作者：

McLaurin, Eugene B. ^{[1
]}

Marsico, Nicholas P. ^{[2
]}

Ciolino, Joseph B. ^{[3
]}

Villanueva, Linda ^{[4
]}

Williams, Julia M. ^{[4
]}

Hollander, David A. ^{[4
]}

机构：

[1] Total Eye Care PA, Memphis, TN USA

[2] East West Eye Inst, Los Angeles, CA USA

[3] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA USA

[4] Allergan Pharmaceut Inc, Irvine, CA 92715 USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2014年 / 133卷 / 02期

关键词：

D O I：

10.1016/j.jaci.2013.12.986

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

961

引用

页码：AB278 / AB278

页数：1

共 50 条

[21] Olopatadine is effective for the prevention and treatment of the signs and symptoms of allergic conjunctivitis
Greiner, JV
Spindel, GP
Gomes, PJ
Vogelson, CT
Amin, D
Bergamini, MVW
Robertson, SM
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U312 - U312
[22] Topical Olopatadine Hydrochloride versus Ketotifen Fumarate for Allergic Conjunctivitis
Patel, Dharmistha
Sarala, N.
Datti, Narendra Panduranga
JOURNAL OF OPHTHALMIC & VISION RESEARCH, 2018, 13 (02) : 119 - 123
[23] Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis
Abelson, Mark B.
Gornes, Paul J.
Pasquine, Terri
Edwards, Michael R.
Gross, Robert D.
Robertson, Stella M.
ALLERGY AND ASTHMA PROCEEDINGS, 2007, 28 (04) : 427 - 433
[24] Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
Wingard, Jeremy B.
Mah, Francis S.
CLINICAL OPHTHALMOLOGY, 2011, 5 : 201 - 207
[25] Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials
Ciolino, Joseph B.
McLaurin, Eugene B.
Marsico, Nicholas P.
Ackerman, Stacey L.
Williams, Julia M.
Villanueva, Linda
Hollander, David A.
CLINICAL OPHTHALMOLOGY, 2015, 9 : 765 - 772
[26] EFFICACY OF OLOPATADINE HYDROCHLORIDE (0.1%) VERSUS KETOTIFEN FUMARATE (0.025%) OPHTHALMIC SOLUTION IN RELIEVING ITCHING IN ALLERGIC CONJUNCTIVITIS IN POPULATION OF PESHAWAR, PAKISTAN
Attique, Usman
Khan, Muhammad Tariq
Aslam, Irfan
Usman, Ahmed
GOMAL JOURNAL OF MEDICAL SCIENCES, 2022, 20 (04): : 203 - 207
[27] Effects of Punctal Occlusion on Ocular Itching and Conjunctival Redness Associated with Allergic Conjunctivitis
Silverstein, Steven M.
Sato, Michelle A.
Meier, Edward J.
Dai, Stella
Bauskar, Aditi
Depperschmidt, Kennedy
Blender, Nysha
Vantipalli, Srilatha
Goldstein, Michael H.
Ozden, Rabia Gurses
CURRENT EYE RESEARCH, 2023, 48 (09) : 781 - 787
[28] A Comparison of the Onset of Action and Duration of Action of Olopatadine Hydrochloride Ophthalmic Solution 0.7% to Loratadine 10 mg in Preventing Ocular Itching in Subjects with Allergic Conjunctivitis
Chin, Jason
Quealy, Kara
Gomes, Paul
Greiner, Jack
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB106 - AB106
[29] Projected 24-hour post-dose ocular itching scores post-treatment with olopatadine 0.7% versus 0.2%
Matthew L. Fidler
Abayomi Ogundele
David Covert
Ramesh Sarangapani
Journal of Pharmacokinetics and Pharmacodynamics, 2018, 45 : 593 - 605
[30] Efficacy of Alcaftadine 0.25% (AGN-229666) for Once-daily Prevention of Cedar-Pollen Allergic Conjunctivitis: A Phase 3 Randomized Study
Fujishima, Hiroshi
Hasunuma, Tomoko
Kawakita, Tetsuya
Sekiya, Takuro
Gomes, Paul
Hollander, David A.
OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (7-8) : 1621 - 1626

← 1 2 3 4 5 →